Apostolidis, L.; Dal Buono, A.; Merola, E.; Jann, H.; Jäger, D.; Wiedenmann, B.; Winkler, E.C.; Pavel, M.
Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3). Cancers 2021, 13, 1936.
https://doi.org/10.3390/cancers13081936
AMA Style
Apostolidis L, Dal Buono A, Merola E, Jann H, Jäger D, Wiedenmann B, Winkler EC, Pavel M.
Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3). Cancers. 2021; 13(8):1936.
https://doi.org/10.3390/cancers13081936
Chicago/Turabian Style
Apostolidis, Leonidas, Arianna Dal Buono, Elettra Merola, Henning Jann, Dirk Jäger, Bertram Wiedenmann, Eva Caroline Winkler, and Marianne Pavel.
2021. "Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)" Cancers 13, no. 8: 1936.
https://doi.org/10.3390/cancers13081936
APA Style
Apostolidis, L., Dal Buono, A., Merola, E., Jann, H., Jäger, D., Wiedenmann, B., Winkler, E. C., & Pavel, M.
(2021). Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3). Cancers, 13(8), 1936.
https://doi.org/10.3390/cancers13081936